Executive record

Steffen Thomas, PhD

Director at ANAVEX LIFE SCIENCES CORP.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:steffen-thomas-phdVersion: public-0As of: 2026-09-29

Not yet claimed8 published Claims3 sources
  • Director

Key Claims

Biography

Steffen Thomas has over 15 years of experience as a European patent attorney and is currently practicing at Epping Hermann Fischer, a major intellectual property law firm in Europe. He previously worked for Takeda Pharmaceutical Company as an in-house patent attorney and has expertise in small molecule pharmaceuticals, patent prosecution, and enforcement.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Board service

Boards

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. AVXL DEF 14A director slate

    sec filing · Source published: Apr 25, 2025 · Retrieved: May 15, 2026

    Supports 6 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Board role: Board role: Director · Claim reviewed: May 15, 2026
    • Committee assignments: Committee assignments: Audit, Nominating/Governance, Compensation · Claim reviewed: May 15, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Executive company: Executive at Epping Hermann Fischer · Claim reviewed: May 15, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 15, 2026

  2. Open source

    sec proxy · Source published: Apr 25, 2025 · Retrieved: Apr 24, 2026

    Supports 1 claim
    • Professional Role: Director at ANAVEX LIFE SCIENCES CORP. · Claim reviewed: May 15, 2026

  3. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of ANAVEX LIFE SCIENCES CORP. · Claim reviewed: May 15, 2026